Your Notifications
All done, no notifications

What is Guillain-Barré Syndrome (GBS)?

Guillain-Barré Syndrome (GBS) is a rare neurological disorder in which the immune system mistakenly attacks the peripheral nerves. This can disrupt nerve signals that control muscle movement and sensation, causing tingling, numbness, and progressive muscle weakness. Weakness often begins in the legs and may spread to the arms and upper body. In severe cases, GBS can cause paralysis, difficulty swallowing or breathing, and abnormalities in heart rate or blood pressure.

What is the Importance of Timely Treatment?

Guillain-Barré Syndrome (GBS) can progress rapidly over hours or days and may affect the muscles responsible for breathing, swallowing and movement. Prompt hospital assessment is essential to monitor respiratory function, heart rate, blood pressure and neurological changes. Doctors may recommend intravenous immunoglobulin (IVIG) or plasma exchange for eligible patients to reduce immune-mediated nerve injury and improve recovery. Supportive care, including intensive care when necessary, helps manage potentially life-threatening complications.

What are the Common Symptoms of Guillain-Barré Syndrome (GBS)?

  • Tingling or pins-and-needles sensations, particularly in the feet or hands
  • Weakness that usually begins in both legs
  • Difficulty walking, climbing stairs or standing
  • Weakness spreading to the arms and upper body
  • Loss or reduction of deep-tendon reflexes
  • Muscle or nerve pain
  • Difficulty with facial movements or facial weakness
  • Difficulty speaking, chewing or swallowing
  • Problems with coordination or balance
  • Abnormal heart rate or blood-pressure fluctuations
  • Difficulty breathing in severe cases
  • Paralysis in severe or rapidly progressive disease

Causes and Risk Factors of Guillain-Barré Syndrome (GBS)

Causes

  • GBS usually develops when an abnormal immune response damages peripheral nerves, often following an infection. Campylobacter jejuni, a bacterium that can cause gastrointestinal infection, is one recognised trigger.
  • Other reported triggers include respiratory or gastrointestinal infections and infections such as influenza, cytomegalovirus, Epstein-Barr virus and Zika virus.
  • In rare cases, GBS may occur after vaccination or surgery, although the absolute risk following vaccination is extremely low.

Risk Factors

  • Recent gastrointestinal or respiratory infection
  • Recent Campylobacter jejuni infection
  • Certain viral infections, including CMV, EBV, influenza or Zika virus
  • Older age
  • Rarely, recent surgery or vaccination
  • Previous GBS, although recurrence is uncommon

Latest Research and Technologies in the Treatment of Guillain-Barré Syndrome (GBS) in Turkey

Specialist neurological centres in Turkey may offer nerve conduction studies, electromyography (EMG), cerebrospinal fluid analysis, IVIG, therapeutic plasma exchange and respiratory monitoring for patients with Guillain-Barré Syndrome (GBS). International research is exploring biomarkers, advanced nerve imaging, and targeted immunotherapies to improve diagnosis and predict recovery. These newer approaches remain under investigation and are not established routine treatments for GBS. The availability of specific diagnostic and treatment services varies by hospital and should be confirmed before treatment.

Treatment options for Guillain-Barré Syndrome (GBS)

Intravenous Immunoglobulin (IVIG): IVIG is an established immunotherapy for GBS that modifies the abnormal immune response responsible for nerve injury. It is generally administered early in the disease course in patients who meet treatment criteria.

Plasma Exchange : Therapeutic plasma exchange removes circulating antibodies and other immune factors from the blood and replaces the plasma component. It can accelerate neurological recovery and is an established treatment for appropriate patients with GBS.

Cost Start From 750Explore Options

  • Clinical assessment:
    • Neurological Evaluation: Assesses muscle strength, sensory changes, reflexes, coordination, gait and the progression of symptoms. Also evaluate facial, swallowing, and respiratory muscle function.
    • Respiratory and Autonomic Monitoring: Evaluates breathing strength, heart rate and blood pressure to identify complications that may require intensive care.
    • Nerve Conduction Studies and Electromyography (EMG): Help identify peripheral nerve dysfunction and characterise the pattern of nerve involvement.
    • Cerebrospinal Fluid (CSF) Analysis: May show elevated protein with a relatively low white blood cell count. Results can be normal early on.
    • Laboratory Tests: May help identify recent infections, metabolic abnormalities or alternative causes of weakness when clinically indicated.
  • Imaging Tests
    • Spinal MRI: A gadolinium-enhanced MRI of the spine may sometimes show thickening and increased contrast uptake in the spinal nerve roots, especially in the lower back.

MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive tele-rehabilitation services designed to support Guillain-Barré Syndrome (GBS) patients in Turkey. These services include:

  • Early Positioning and Mobility: Physiotherapists help maintain safe positioning, joint mobility and circulation during the acute phase while avoiding excessive fatigue or muscle injury.
  • Strength and Motor Rehabilitation: As nerve function begins to recover, progressive exercises can help rebuild muscle strength, balance, coordination and functional movement.
  • Walking and Functional Training: Patients with lower-limb weakness may receive gait training, transfer practice and assistive-device support to gradually regain mobility and independence.
  • Speech and Swallowing Rehabilitation: Speech and language therapists may help patients with facial weakness, speech difficulties or swallowing problems and support safe nutrition when bulbar muscles are affected.
  • Occupational and Psychological Support: Occupational therapy can help patients regain independence in daily activities, while psychological support may help with anxiety, frustration, fatigue and adjustment during a prolonged recovery.
  • The principal disease-modifying treatments for GBS are intravenous immunoglobulin (IVIG) and therapeutic plasma exchange. Both are established options for eligible patients and have broadly similar effectiveness. Clinicians do not routinely combine them sequentially because this has not shown a clear additional benefit. Other medicines may be prescribed to manage neuropathic pain, musculoskeletal discomfort or specific complications.

Instantly Connect with our Specialists

Doctor 1
Doctor 2
Doctor 3
Doctor 4
Doctor 5
Doctor 6
Doctor 7
Doctor 8

Hospitals for Guillain-Barré Syndrome (GBS) in Turkey

Medipol Bahçelievler Hospital: Top Doctors, and Reviews
Medipol Bahçelievler Hospital

Istanbul, Turkey

Medipol Bahcelievler Hospital is a medical institution providing a full range of medical and individualized approaches to its patients. Medipol has the ambition to bring high quality and maximum security to people in need by employing state-of-the-art technologies in medicine. They ensure that the health of the patients is improved by fashioning unique physician specialty treatment programs.

Medipol Bahcelievler Hospital provides an exceptional position in the healthcare industry with a policy of clear communication, professionalism, and reliability to patient expectations. Medipol Bahçelievler Hospital is situated in the European Side of Istanbul, dedicated to 24-hour health care for you and your loved ones, equipped with a fully functional operation theatre and ICUs with state-of-the-art equipment, laboratory, emergency, and advanced treatment rooms

Message Us

296

PROCEDURE

19

DOCTORS IN 16 SPECIALITIES

19+

FACILITIES & AMENITIES

Medstar Antalya Hospital: Top Doctors, and Reviews
Medstar Antalya Hospital

Ankara, Turkey

  • Medstar Antalya Hospital has been providing patients with modern medical services since 2009.
  • It is part of the trusted Memorial Health Group, which is known for expert healthcare in Turkey.
  • The hospital is situated on a large campus and features advanced medical equipment and facilities.
  • It has 124 comfortable beds for patients and five fully prepared operating rooms for surgeries.
  • There are 33 intensive care beds, including specialised units for newborns who require additional support.
  • The hospital treats many health issues like cancer, heart problems, brain conditions, and more.
  • Modern machines, such as MRI, CT, and PET-CT, help doctors identify and treat problems quickly and safely.
  • Medstar meets international safety and care standards and is trusted by both local and global patients.
  • Care plans are made specially for each person, and emotional well-being is also supported.
  • Its location in Antalya makes it easy to reach and ideal for people coming from other countries for treatment.
Message Us

287

PROCEDURE

16

SPECIALITIES

25+

FACILITIES & AMENITIES

Our Services to better your experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Why Choose Turkey for Guillain-Barré Syndrome (GBS) Treatment?

  • Multidisciplinary Neurological Care: Patients can access neurologists, neurocritical-care specialists, physiotherapists, respiratory specialists, and rehabilitation teams as needed.
  • Advanced Neurological Diagnostics: Specialised centres may provide nerve conduction studies, EMG, lumbar puncture, advanced imaging and continuous neurological monitoring.
  • Immunotherapy Facilities: Major neurological centres can provide IVIG and therapeutic plasma exchange for appropriately selected patients.
  • Critical and Respiratory Care: Severe GBS may require intensive care, ventilatory support, cardiac monitoring and management of autonomic complications.
  • Comprehensive Rehabilitation and International Patient Support: Physiotherapy, occupational therapy, speech and swallowing rehabilitation, nutritional support and international-patient coordination can be incorporated into the treatment pathway.

Frequently Asked Questions

Recovery varies considerably depending on the severity of nerve damage, how rapidly symptoms progressed and the presence of complications. Many people begin to recover within a few weeks after the acute phase, but regaining strength and independence can take several months. Some patients may require rehabilitation for a year or longer, and a proportion may have persistent weakness or other nerve-related symptoms.

Some people with mild GBS can continue walking, while others temporarily lose the ability to walk because of progressive muscle weakness. Walking ability can change rapidly during the acute phase. Rehabilitation and gradual strengthening can help patients regain mobility as nerve function recovers.

Specialised hospitals in Turkey may offer nerve conduction studies, electromyography (EMG), cerebrospinal fluid analysis, intravenous immunoglobulin (IVIG), therapeutic plasma exchange and respiratory monitoring for GBS. Patients with severe disease may also require intensive care and ventilatory support. Available facilities vary by hospital, so patients should confirm that the selected centre can provide the necessary neurological and emergency care.

Many major hospitals in Turkey have international-patient departments that may assist with medical records, specialist appointments, treatment coordination, accommodation and travel arrangements. Services vary by hospital, so patients should confirm arrangements directly. Because GBS can progress rapidly, do not delay urgent medical treatment for international travel.

Consider a centre with experienced neurologists and access to IVIG, plasma exchange, electrophysiological testing, respiratory monitoring and intensive neurological care. If significant weakness is present, access to neurocritical care and a multidisciplinary rehabilitation programme is also important.

Treatment outcomes depend on GBS severity, the extent of nerve damage, respiratory involvement, complications, and treatment timing. Most patients recover substantially, although recovery may take months and some may have lasting weakness, fatigue, pain or sensory symptoms. IVIG or plasma exchange can improve recovery in eligible patients, while supportive care helps manage serious complications. A neurologist can discuss the likely outcome based on the patient's condition and response to treatment.

Neurologists and neurocritical-care specialists at specialised Turkey centres manage GBS, including rapidly progressive weakness, respiratory complications, autonomic dysfunction and treatment with IVIG or plasma exchange. Patients with severe disease may benefit from centres with intensive-care and comprehensive rehabilitation facilities.

Risks depend on the treatment and the patient's condition. IVIG can cause treatment-related adverse effects, while plasma exchange may cause complications related to vascular access, fluid balance, blood pressure or infection. Intensive-care treatments and mechanical ventilation can also cause complications. The risks of untreated or rapidly progressive GBS can be serious because the condition may affect breathing, swallowing, heart rate and blood pressure.

Seek urgent medical assessment if you develop new or progressive muscle weakness, tingling with weakness, difficulty walking, facial weakness, or swallowing difficulties. Difficulty breathing, choking, fainting or rapidly worsening weakness warrants emergency care. Suspected GBS generally requires hospital assessment and close monitoring because respiratory or autonomic complications can become life-threatening.

GBS does not typically cause structural physical deformities. However, severe or prolonged nerve damage can leave some patients with persistent muscle weakness, reduced mobility, neuropathic pain or other functional limitations. Most people recover substantially, although recovery may take months or longer.

Yes. Weakness, fatigue, pain, difficulty walking and prolonged rehabilitation can affect work, education, self-care, mobility and emotional well-being. Early supportive care and a structured rehabilitation programme can help patients regain independence and adapt to any persistent symptoms.

Yes. Rapidly progressive or untreated GBS can cause severe paralysis, respiratory failure, swallowing difficulties, autonomic instability and other potentially life-threatening complications. Some patients may also develop persistent weakness, sensory symptoms, fatigue or pain after the acute illness.

It is an abnormal immune response that can occur after different infections and, rarely, other triggers. Reducing infection risk through proper food and water hygiene, hand hygiene, and recommended preventive measures may reduce exposure to some recognised triggers. Vaccination remains an important preventive health measure, and the risk of GBS after vaccination is very low compared with the risk from some infections.

GBS can affect people of any age, but it is more common in adults and males, with risk generally increasing with age. It often occurs following a gastrointestinal or respiratory infection, although some people develop GBS without an identifiable trigger.

Author

Dr. Vijita Jayan
Dr. Vijita Jayan

BPT, MPT (Neuro)

18 Years of Experience

With over 18 years of distinguished clinical experience, Dr. Vijita Jayan is a highly accomplished Clinical Director and Rehabilitation Specialist, renowned for her expertise in neuro-rehabilitation, functional recovery, and mobility-dependent case management. Her extensive practical knowledge enables her to design and implement individualized, evidence-based rehabilitation protocols that consistently yield measurable patient outcomes. A prolific researcher and academic writer, she has authored numerous peer-reviewed articles and research papers, significantly advancing the field of rehabilitative medicine. The recipient of multiple prestigious accolades, Dr. Jayan is widely regarded as one of the foremost authorities in Physical Medicine and Rehabilitation, continually shaping neuro-rehabilitative care through research, innovation, and clinical excellence. View More

Reviewer

Dr. Akash Khandelwal
Dr. Akash Khandelwal

Hematologist

9 Years of Experience

Dr. Akash Khandelwal is a distinguished Hematologist, Hemato-oncologist, and Bone Marrow Transplant (BMT) Physician with extensive training from the prestigious AIIMS New Delhi. His expertise encompasses a wide range of specialized techniques in bone marrow transplantation, including autologous and allogeneic transplants such as matched sibling donors, matched unrelated donors (MUD), and haploidentical donor transplants. Dr. Khandelwal has personally supervised and conducted over 100 bone marrow transplants. View More

Last Reviewed - January 2026